Antiterror Agenda Promotes Ebola Vaccine and Immunotherapy

Photo © Alfred Pasieka, SPL, Photo Researchers Inc. RNA RAIDERS: Computer artwork depicts Ebola viruses releasing their RNA inside an infected human cell. RNA strands are in the upper right. Tightly packed segments of released RNA float through the cell. Though smallpox and anthrax loom as the likeliest boogeymen in a bioterrorism nightmare, the rare Ebola virus still evokes particular dread. This untreatable virus rapidly kills 80% to 90% of the humans it infects, and no one knows w

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Though smallpox and anthrax loom as the likeliest boogeymen in a bioterrorism nightmare, the rare Ebola virus still evokes particular dread. This untreatable virus rapidly kills 80% to 90% of the humans it infects, and no one knows where it lurks in the years between its small-scale outbreaks, up to now confined to central Africa. Scientists in the former Soviet Union reportedly weaponized the virus.1

The US Centers for Disease Control and Prevention (CDC) listed Ebola as a "select agent" in 1996, meaning that at least three antiterrorism statutes regulate it. Ebola is also one of the potential bioterrorism agents now targeted by the National Institute of Allergy and Infectious Diseases. NIAID is seeking $1.4 billion for biodefense in fiscal 2003, a $1.2 billion jump over 2002. The National Institutes of Health (NIH) "has had a longstanding commitment to work on emerging infectious diseases, and this is a huge opportunity ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Douglas Steinberg

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio